Horse Profile

Screener/Lace Flower (IRE)

Lace Flower (IRE)

3yo Filly · ·

Career Overview

Lace Flower (IRE) is a 3yo filly, trained by H-A Pantall and owned by Godolphin Snc. He is by Sea The Stars (IRE), out of Threading (IRE), by Exceed And Excel. From 4 career starts, he has won 1 time, placed on 1 occasion, at a 25.0% strike rate.

AI summary — career highlights, form & what to expect
Form
4198
Active

Age

3

Sex

Filly

Colour

OR

—

TF

—

Runs

4

Wins

1

Places

1

Breeder—
Prize Money£0

Performance Metrics

Win Rate

25.0%

Place Rate

25.0%

Total Runs

4

Best OR

—

Career Earnings

£0

Smart Signals

🌿Surface preferenceTurf — 1w from 4r (25%)

Upcoming Entries

1 entry
DateCourseRace
2026-10-16ToulousePrix De La Ville De Balma

Ratings & Form History

Official Rating · Speed Figure · Finishing Position

22 Jul 2617 Aug 2628 Sep 2616 Oct 26
  • Finish Pos.
  • Off. Rating
  • Speed Fig.

Earnings Per Race

£9.5k total
28 Sep 2616 Oct 26£0£2k£4k£6k£8k

Pedigree

Breeder

—

Racing TypeFlat
Colour
StatusActive

Performance Analysis

Going Preference

Soft2
0W 0P 0%
Good To Soft2
1W 1P 50%

Seasonal Form

Sept1
1W 1P 100%
Jul1
0W 0P 0%
Aug1
0W 0P 0%
Oct1
0W 0P 0%

Headgear Impact

Without4
1W 1P 25%

Draw Performance

Low (1-3)2
0W 0P · Avg 8.5
Mid (4-6)1
0W 0P · Avg 4.0
High (7+)1
1W 1P · Avg 1.0

Jockey Record

Tony Piccone3
1W 1P 33%
Martin Protti1
0W 0P 0%

Course Form

Beaten Distances

Avg Win Margin

0.0L

Avg Beaten

1.2L

Closest Loss

0.1L

Market Trend (Starting Price)

22 Jul 2617 Aug 2628 Sep 2616 Oct 260481216
  • SP (dec)
  • BSP

Race History

Race History

DatePosTrackRaceDistGoingJockeySPORSpeed
16 Oct 20264Toulouse (FR)Prix De La Ville De Balma8ffSoftTony Piccone5/2F——
28 Sep 20261Bordeaux Le Bouscat (FR)Prix De L'hippodrome De Mont-de-marsan8ffGood To SoftTony Piccone7/2——
17 Aug 20269Mont-De-Marsan (FR)Prix Des Montois8ffGood To SoftMartin Protti2/1F——
22 Jul 20268Vichy (FR)Prix De Vernusse7ffSoftTony Piccone8/1——

Discussion

0 comments

You must be logged in to leave a comment.

No comments yet

Be the first to share your thoughts